Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-jun Zou

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Molecular Cancer|March 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trialSong-Yang Wu, Ying Xu, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
The New England Journal of Medicine|March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic CholangiocarcinomaGuo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Molecular Cancer|March 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trialSong-Yang Wu, Ying Xu, Li Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2022
Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II TrialLi Chen, Yi-Zhou Jiang, Song-Yang Wu, et al.
The New England Journal of Medicine|March 4, 2026
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic CholangiocarcinomaGuo-Ming Shi, Xiao-Yong Huang, Fei Liang, et al.
Pageof 5